The prognostic association of prostate MRI PI-RADS™ v2 assessment category and risk of biochemical recurrence after definitive local therapy for prostate cancer: a …

P Rajwa, K Mori, NA Huebner, DT Martin… - Journal of …, 2021 - journals.lww.com
Purpose: Although the Prostate Imaging–Reporting and Data System™ version 2 (PI-
RADS™ v2) is a reliable diagnostic tool for significant prostate cancer, less is known about …

Relationship of prostate cancer topography and tumour conspicuity on multiparametric magnetic resonance imaging: a protocol for a systematic review and meta …

P Satish, A Freeman, D Kelly, A Kirkham, C Orczyk… - BMJ open, 2022 - bmjopen.bmj.com
Introduction Multiparametric magnetic resonance imaging (mpMRI) has improved the triage
of men with suspected prostate cancer, through precision prebiopsy identification of …

Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer …

A Lophatananon, MHV Byrne, T Barrett, A Warren… - BMC cancer, 2022 - Springer
Introduction Pre-treatment risk and prognostic groups are the cornerstone for deciding
management in non-metastatic prostate cancer. All however, were developed in the pre-MRI …

The prognostic value of PI-RADS score in CyberKnife ultra-hypofractionated radiotherapy for localized prostate cancer

M Miszczyk, J Rembak-Szynkiewicz, Ł Magrowski… - Cancers, 2022 - mdpi.com
Simple Summary Magnetic resonance imaging is commonly used in pre-treatment prostate
cancer diagnostics. The assessment includes a five-stage scale classification called …

[PDF][PDF] New stability indicating method development and validation of Capecitabine and docetaxel in bulk and pharmaceutical dosage form by using RP-HPLC

N Tirumalasetty, D Ramchandran - Int. J. Appl. Pharm., 2021 - academia.edu
Objective: The current investigation was pointed at developing and progressively validating
novel, simple, responsive and stable RP-HPLC method for the measurement of active …

Tumour microenvironment and focal therapy for prostate cancer

RC Borges, RR Tourinho-Barbosa… - Current Opinion in …, 2022 - journals.lww.com
A better understanding of TME has the potential to reliably elucidate PCa heterogeneity and
assign a prognostic profile in accordance with prostate tumour foci. The joint contribution of …

[HTML][HTML] Protocol: Relationship of prostate cancer topography and tumour conspicuity on multiparametric magnetic resonance imaging: a protocol for a systematic …

P Satish, A Freeman, D Kelly, A Kirkham, C Orczyk… - BMJ Open, 2022 - ncbi.nlm.nih.gov
Introduction Multiparametric magnetic resonance imaging (mpMRI) has improved the triage
of men with suspected prostate cancer, through precision prebiopsy identification of …

Evaluating novel prognostic biomarkers in prostate cancer

BS Simpson - 2022 - discovery.ucl.ac.uk
Prostate cancer (PCa) is a major world health issue, killing 358,989 men worldwide each
year. Predicting a disease's likely course (prognosis), is a fundamental question in oncology …

Does modern active surveillance offer an opportunity for new therapeutic strategies in early prostate cancer?

VJ Gnanapragasam, T Barrett, S Pacey… - BJU …, 2021 - search.ebscohost.com
Abbreviations AR androgen receptor AS active surveillance National and international
guidelines endorse active surveillance (AS) as the preferred method of managing men with …

Suspicion de cancer de la prostate et IRM négative: implications diagnostiques et pour la surveillance active

J Olivier - 2021 - theses.hal.science
Le dépistage du cancer de la prostate, réalisé par dosage sérique du PSA et toucher rectal,
permet une diminution de la mortalité spécifique de 21% à 13 ans. Le diagnostic de lésions …